Aeolus Pharmaceuticals Inc (OTCQB:AOLS)

0.2899
Delayed Data
As of 2:34pm ET
 +0.0099 / +3.54%
Today’s Change
0.19
Today|||52-Week Range
0.55
+26.04%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$38.0M

Company Description

Aeolus Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the business of developing platform of broad-spectrum, catalytic antioxidant compounds that protect healthy tissue from the damaging effects of oxidative stress development of medical countermeasures against biological, chemical and radiological weapons in the U. S. It also develops medical countermeasures for diseases and disorders of the central nervous system, respiratory system, autoimmune system, and oncology. The company was founded by Brian J. Day in 1994 and is headquartered in Mission Viejo, CA.

Contact Information

Aeolus Pharmaceuticals, Inc.
26361 Crown Valley Parkway
Mission Viejo California 92691
P:(949) 481-9825
Investor Relations:

Employees

Shareholders

Individual stakeholders90.51%
Mutual fund holders--
Other institutional--

Top Executives

David C. CavalierChairman, Chief Financial Officer & Secretary
John L. McManusPresident & Chief Executive Officer
Christopher StanleyVice President-Operations
Brian J. DayChief Scientific Officer

To view my watchlist

Not a member yet?

Sign up now for a free account